Form 4 for HUMA Humacyte, Inc.
Accepted 2023-11-21 00:00:00 ET · period of report 2023-11-21 · accession 0001818382-23-000165 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-21 | 2023-11-21 | HUMA | Wallace Max N. | Dir | M - OptEx | $1.19 | +6,564 | 56.5K | +13% | +$7,811 |
| D | 2023-11-21 | 2023-11-21 | HUMA | Wallace Max N. | Dir | M - OptEx | $0.00 | -6,564 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-21 | M | A | 6,564 | $1.19 | 56,550 | D | — | — | |
| 2 | Derivative | Stock Options (right to buy) | 2023-11-21 | M | D | 6,564 | $0.00 | 0 | D | $1.19 · 2016-11-22 to 2023-11-22 | 6,564 Common Stock |